Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Technology | FFR Technologies

May 22 2018 — Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis ...

Home May 22, 2018
Home
News | Thrombectomy Devices

May 21, 2018 — Medtronic and the U.S. Food and Drug Administration (FDA) announced a Class I Urgent Medical Device ...

Home May 21, 2018
Home
News | Heart Failure

May 16, 2018 — Israel-based V-Wave Ltd. recently closed a $70 million Series C financing for its proprietary, minimally ...

Home May 16, 2018
Home
News | Interventional Radiology

May 15, 2018 — U.S. First Lady Melania Trump underwent an interventional radiology embolization procedure to treat a ...

Home May 15, 2018
Home
News | Atrial Fibrillation

May 15, 2018 – Results of the AVIATOR 2 international registry data show a discrepancy between physician perception and ...

Home May 15, 2018
Home
News | Peripheral Artery Disease (PAD)

May 15, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to ...

Home May 15, 2018
Home
News | Cath Lab

May 15, 2018 — Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutan ...

Home May 15, 2018
Home
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab

May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal ...

Home May 15, 2018
Home
News | Cath Lab

May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used ...

Home May 15, 2018
Home
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018
Feature | Cardiovascular Clinical Studies

May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin ...

Home May 14, 2018
Home
A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.
Feature | Heart Valve Technology

May 14, 2018 – A new study finds patients who stay in the hospital for more than 72 hours when undergoing trans-femoral ...

Home May 14, 2018
Home
News | Chronic Total Occlusion (CTO)

May 14, 2018 – One-year outcomes of patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention ...

Home May 14, 2018
Home
News | Heart Valve Technology

May 14, 2018 – A new study examines the effectiveness of 3-D printing technology and computer modeling to predict ...

Home May 14, 2018
Home
News | Peripheral Artery Disease (PAD)

May 14, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD ...

Home May 14, 2018
Home
News | Chronic Total Occlusion (CTO)

May 14, 2018 — A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total ...

Home May 14, 2018
Home
Subscribe Now